Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Sipuleucel-T> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Sipuleucel-T abstract "Sipuleucel-T (APC8015, trade name Provenge), manufactured by Dendreon Corporation, is a therapeutic cancer vaccine for prostate cancer (CaP). It must be prepared specifically for each patient. In metastatic prostate cancer, it has extended survival by median 4.1 months (IMPACT Phase III trial data). The treatment costs $93,000.".
- Sipuleucel-T atcPrefix "L03".
- Sipuleucel-T atcSuffix "AX17".
- Sipuleucel-T casNumber "917381-47-6".
- Sipuleucel-T fdaUniiCode "8Q622VDR18".
- Sipuleucel-T wikiPageExternalLink lookup.cfm?setid=8309b497-5d4e-4408-ac0c-2452c11c8a35.
- Sipuleucel-T wikiPageExternalLink sthash.ksB7rcs4.Uh8V5LId.dpuf,.
- Sipuleucel-T wikiPageExternalLink ViewAbstract.aspx?mID=3086&sKey=8dc35a86-d973-4f4b-abdd-717b8e5c4096&cKey=26207d5b-db55-4851-95fc-17c7ba2446e2&mKey=%7b9B2D28E7-24A0-466F-A3C9-07C21F6E9BC9%7d.
- Sipuleucel-T wikiPageExternalLink ucm210012.htm.
- Sipuleucel-T wikiPageExternalLink UCM210031.pdf.
- Sipuleucel-T wikiPageExternalLink www.provenge.com.
- Sipuleucel-T wikiPageExternalLink 33-9488.pdf.
- Sipuleucel-T wikiPageID "28568276".
- Sipuleucel-T wikiPageRevisionID "606552763".
- Sipuleucel-T atcPrefix "L03".
- Sipuleucel-T atcSuffix "AX17".
- Sipuleucel-T casNumber "917381".
- Sipuleucel-T chembl "1237024".
- Sipuleucel-T chemspiderid "NA".
- Sipuleucel-T colwidth "30".
- Sipuleucel-T drugName "Sipuleucel-T".
- Sipuleucel-T hasPhotoCollection Sipuleucel-T.
- Sipuleucel-T kegg "D06644".
- Sipuleucel-T legalUs "Rx-only".
- Sipuleucel-T medlineplus "a611025".
- Sipuleucel-T pregnancyCategory "N/A".
- Sipuleucel-T pubchemsubstance "85151648".
- Sipuleucel-T routesOfAdministration Intravenous_therapy.
- Sipuleucel-T target Prostate_cancer.
- Sipuleucel-T tradename "Provenge".
- Sipuleucel-T type "vaccine".
- Sipuleucel-T unii "8".
- Sipuleucel-T vaccineType "protein subunit".
- Sipuleucel-T verifiedfields "changed".
- Sipuleucel-T verifiedrevid "423050273".
- Sipuleucel-T watchedfields "changed".
- Sipuleucel-T subject Category:Cancer_vaccines.
- Sipuleucel-T type Antigen115037339.
- Sipuleucel-T type CancerVaccines.
- Sipuleucel-T type Immunogen103562739.
- Sipuleucel-T type Matter100020827.
- Sipuleucel-T type PhysicalEntity100001930.
- Sipuleucel-T type Substance100020090.
- Sipuleucel-T type Vaccine104517535.
- Sipuleucel-T type Drug.
- Sipuleucel-T type FunctionalSubstance.
- Sipuleucel-T comment "Sipuleucel-T (APC8015, trade name Provenge), manufactured by Dendreon Corporation, is a therapeutic cancer vaccine for prostate cancer (CaP). It must be prepared specifically for each patient. In metastatic prostate cancer, it has extended survival by median 4.1 months (IMPACT Phase III trial data). The treatment costs $93,000.".
- Sipuleucel-T label "Sipuleucel-T".
- Sipuleucel-T label "Sipuleucel-T".
- Sipuleucel-T label "Sipuleucel-T".
- Sipuleucel-T sameAs Sipuleucel-T.
- Sipuleucel-T sameAs Sipuleucel-T.
- Sipuleucel-T sameAs m.04kksb5.
- Sipuleucel-T sameAs Q424057.
- Sipuleucel-T sameAs Q424057.
- Sipuleucel-T sameAs Sipuleucel-T.
- Sipuleucel-T wasDerivedFrom Sipuleucel-T?oldid=606552763.
- Sipuleucel-T homepage www.provenge.com.
- Sipuleucel-T isPrimaryTopicOf Sipuleucel-T.
- Sipuleucel-T name "Sipuleucel-T".